These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20373244)

  • 1. Biomarkers - SMi's Third Summit: discovery, validation & qualification.
    French N
    IDrugs; 2010 Apr; 13(4):204-8. PubMed ID: 20373244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma & COPD - SMi's sixth annual conference.
    Shah S
    IDrugs; 2010 Jun; 13(6):376-8. PubMed ID: 20506058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R
    IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of biomarkers in nephropharmacology.
    Khan E; Batuman V; Lertora JJ
    Biomark Med; 2010 Dec; 4(6):805-14. PubMed ID: 21133700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
    Walker G
    IDrugs; 2009 Nov; 12(11):673-4. PubMed ID: 19844848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and Progress in Drug Design - SMi's ninth annual meeting.
    Welchman R
    IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
    Edwards C
    IDrugs; 2010 Jul; 13(7):433-6. PubMed ID: 20582864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superbugs and Superdrugs-SMi's 12th annual conference--Overcoming resistance. 17-18 March 2010, London, UK.
    Oni A
    IDrugs; 2010 May; 13(5):314-6. PubMed ID: 20432187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformative biomarkers for drug-induced liver injury: are we there yet?
    Antoine DJ; Dear JW
    Biomark Med; 2017 Feb; 11(2):103-106. PubMed ID: 28097885
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
    Beger RD; Sun J; Schnackenberg LK
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):154-66. PubMed ID: 19932708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Opinion Leaders - SMi's Second Conference Knowledge Leaders.
    Mason VL
    IDrugs; 2009 Dec; 12(12):770-3. PubMed ID: 19943219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Safety Strategies to De-Risk Compounds--an IBC conference. 4-6 August 2009, Boston, MA, USA.
    Mattes W
    IDrugs; 2009 Oct; 12(10):623-6. PubMed ID: 19790010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMi's Conducting Clinical Trials in Europe.
    Jago C
    IDrugs; 2009 Dec; 12(12):754-9. PubMed ID: 19943216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in cancer - SMi's Seventh Annual Conference.
    Fakorede A
    IDrugs; 2008 Sep; 11(9):627-9. PubMed ID: 18763208
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.
    Kane-Gill SL; Smithburger PL; Kashani K; Kellum JA; Frazee E
    Drug Saf; 2017 Nov; 40(11):1049-1074. PubMed ID: 28674842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualification of translational safety biomarkers.
    Sauer JM; Porter AC
    Exp Biol Med (Maywood); 2021 Nov; 246(22):2391-2398. PubMed ID: 33757340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
    Dadarkar SS; Fonseca LC; Mishra PB; Lobo AS; Doshi LS; Dagia NM; Rangasamy AK; Padigaru M
    J Appl Toxicol; 2011 Mar; 31(2):117-30. PubMed ID: 20623750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.